Busarin Arunsak
About
Busarin Arunsak is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Physiology.
According to data from OpenAlex, Busarin Arunsak has authored 67 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 22 papers in Cardiology and Cardiovascular Medicine and 20 papers in Physiology. Recurrent topics in Busarin Arunsak's work include Mitochondrial Function and Pathology (13 papers), Cardiac Ischemia and Reperfusion (11 papers) and Chemotherapy-induced cardiotoxicity and mitigation (11 papers). Busarin Arunsak is often cited by papers focused on Mitochondrial Function and Pathology (13 papers), Cardiac Ischemia and Reperfusion (11 papers) and Chemotherapy-induced cardiotoxicity and mitigation (11 papers). Busarin Arunsak collaborates with scholars based in Thailand, China and United States. Busarin Arunsak's co-authors include Titikorn Chunchai, Siriporn C. Chattipakorn, Nipon Chattipakorn, Chayodom Maneechote, Benjamin Ongnok, Thawatchai Khuanjing, Nattayaporn Apaijai, Wichwara Nawara, Apiwan Arinno and Nanthip Prathumsap and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.
In The Last Decade
Busarin Arunsak
61 papers receiving 664 citations
Peers
Busarin Arunsak
Benjamin Ongnok Thailand
Dong Sun China
Chayodom Maneechote Thailand
Simona Marchitti Italy
Safia Ogbi United States
Roberto Paternò Italy
Mallikarjuna R. Pabbidi United States
Kazuo Yano Japan
Sebastian Benkhoff Germany
Citations per year, relative to Busarin Arunsak Busarin Arunsak (= 1×)
peers
Benjamin Ongnok
Countries citing papers authored by Busarin Arunsak
Since
Specialization
Citations
This map shows the geographic impact of Busarin Arunsak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Busarin Arunsak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Busarin Arunsak more than expected).
Fields of papers citing papers by Busarin Arunsak
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Busarin Arunsak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Busarin Arunsak. The network helps show where Busarin Arunsak may publish in the future.
Co-authorship network of co-authors of Busarin Arunsak
This figure shows the co-authorship network connecting the top 25 collaborators of Busarin Arunsak. A scholar is included among the top collaborators of Busarin Arunsak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Busarin Arunsak. Busarin Arunsak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Maneechote, Chayodom, Thawatchai Khuanjing, Benjamin Ongnok, et al.. (2025). Targeting mitochondrial dynamics emerges as an effective strategy of cardioprotection against trastuzumab-induced mitochondrial functional aberrations and cardiotoxicity in rats. European Journal of Pharmacology. 999. 177685–177685.
2.
Kumfu, Sirinart, Jirapas Sripetchwandee, Chanisa Thonusin, et al.. (2025). Mitochondrial dynamic modulators attenuate iron overload-mediated cardiac toxicity via decreased mitochondrial fission, mitophagy/autophagy, and apoptosis in iron-overloaded rats. Archives of Biochemistry and Biophysics. 767. 110354–110354.
3.
Prathumsap, Nanthip, Benjamin Ongnok, Thawatchai Khuanjing, et al.. (2024). Muscarinic and nicotinic receptors stimulation by vagus nerve stimulation ameliorates trastuzumab-induced cardiotoxicity via reducing programmed cell death in rats. Toxicology and Applied Pharmacology. 491. 117074–117074.
4.
Maneechote, Chayodom, Busarin Arunsak, Titikorn Chunchai, et al.. (2024). Chronic mitochondrial dynamic-targeted therapy alleviates left ventricular dysfunction by reducing multiple programmed cell death in post-myocardial infarction rats. European Journal of Pharmacology. 977. 176736–176736.
5.
Apaijai, Nattayaporn, Hiranya Pintana, Busarin Arunsak, et al.. (2024). Inhibition of 5-alpha reductase attenuates cardiac oxidative damage in obese and aging male rats via the enhancement of antioxidants and the p53 protein suppression. Chemico-Biological Interactions. 403. 111240–111240.
6.
Thonusin, Chanisa, Titikorn Chunchai, Hiranya Pintana, et al.. (2023). Long-term lifestyle intervention is superior to transient modification for neuroprotection in D-galactose-induced aging rats. Life Sciences. 334. 122248–122248.
7.
Prathumsap, Nanthip, Benjamin Ongnok, Thawatchai Khuanjing, et al.. (2023). Acetylcholine receptor agonists effectively attenuated multiple program cell death pathways and improved left ventricular function in trastuzumab-induced cardiotoxicity in rats. Life Sciences. 329. 121971–121971.
8.
Ongnok, Benjamin, Nanthip Prathumsap, Thawatchai Khuanjing, et al.. (2023). Vagus Nerve Stimulation Provides Neuroprotection Against Doxorubicin‐induced Chemobrain Via Activations of Both Muscarinic and Nicotinic Acetylcholine Receptors. Alzheimer s & Dementia. 19(S13).
9.
Maneechote, Chayodom, Busarin Arunsak, Titikorn Chunchai, et al.. (2023). GSDMD-mediated pyroptosis dominantly promotes left ventricular remodeling and dysfunction in post-myocardial infarction: a comparison across modes of programmed cell death and mitochondrial involvement. Journal of Translational Medicine. 21(1). 16–16.
10.
Khuanjing, Thawatchai, Chayodom Maneechote, Benjamin Ongnok, et al.. (2023). Acetylcholinesterase inhibition protects against trastuzumab-induced cardiotoxicity through reducing multiple programmed cell death pathways. Molecular Medicine. 29(1). 123–123.
11.
Pratchayasakul, Wasana, Natthaphat Siri‐Angkul, Benjamin Ongnok, et al.. (2023). Cyclosorus Terminans Extract Alleviates Neuroinflammation in Insulin Resistant Rats. Molecular Neurobiology. 61(7). 4879–4890.
12.
Prathumsap, Nanthip, Benjamin Ongnok, Thawatchai Khuanjing, et al.. (2022). Vagus nerve stimulation exerts cardioprotection against doxorubicin-induced cardiotoxicity through inhibition of programmed cell death pathways. Cellular and Molecular Life Sciences. 80(1). 21–21.
13.
Thonusin, Chanisa, Wichwara Nawara, Thawatchai Khuanjing, et al.. (2022). Blood metabolomes as non-invasive biomarkers and targets of metabolic interventions for doxorubicin and trastuzumab-induced cardiotoxicity. Archives of Toxicology. 97(2). 603–618.
14.
Ongnok, Benjamin, Chayodom Maneechote, Titikorn Chunchai, et al.. (2022). Modulation of mitochondrial dynamics rescues cognitive function in rats with ‘doxorubicin‐induced chemobrain’ via mitigation of mitochondrial dysfunction and neuroinflammation. FEBS Journal. 289(20). 6435–6455.
15.
Luo, Ying, Nattayaporn Apaijai, Chayodom Maneechote, et al.. (2022). Therapeutic potentials of cell death inhibitors in rats with cardiac ischaemia/reperfusion injury. Journal of Cellular and Molecular Medicine. 26(8). 2462–2476.
16.
Arinno, Apiwan, Chayodom Maneechote, Thawatchai Khuanjing, et al.. (2021). Abstract 9375: Melatonin and Metformin Exert Cardioprotection Against Trastuzumab-induced Cardiotoxicity Through Modulating Cardiac Mitochondrial Dynamics in Rats. Circulation. 144(Suppl_1).
17.
Apaijai, Nattayaporn, Ying Luo, Jun Wu, et al.. (2021). Cell death inhibitors protect against brain damage caused by cardiac ischemia/reperfusion injury. Cell Death Discovery. 7(1). 312–312.
18.
Khuanjing, Thawatchai, Benjamin Ongnok, Chayodom Maneechote, et al.. (2021). Acetylcholinesterase inhibitor ameliorates doxorubicin-induced cardiotoxicity through reducing RIP1-mediated necroptosis. Pharmacological Research. 173. 105882–105882.
19.
Arunsak, Busarin, Wasana Pratchayasakul, Sasiwan Kerdphoo, et al.. (2020). Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor exerts greater efficacy than atorvastatin on improvement of brain function and cognition in obese rats. Archives of Biochemistry and Biophysics. 689. 108470–108470.
20.
Palee, Siripong, Busarin Arunsak, Wasana Pratchayasakul, et al.. (2020). PCSK9 inhibitor and atorvastatin reduce cardiac impairment in ovariectomized prediabetic rats via improved mitochondrial function and Ca2+ regulation. Journal of Cellular and Molecular Medicine. 24(16). 9189–9203.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Benjamin Ongnok Breakdown of academic impact, for papers by Dong Sun Breakdown of academic impact, for papers by Chayodom Maneechote Breakdown of academic impact, for papers by Simona Marchitti Breakdown of academic impact, for papers by Safia Ogbi Breakdown of academic impact, for papers by Roberto Paternò Breakdown of academic impact, for papers by Mallikarjuna R. Pabbidi Breakdown of academic impact, for papers by Kazuo Yano Breakdown of academic impact, for papers by Sebastian Benkhoff